The IgG-specific endoglycosidase EndoS inhibits both cellular and complement-mediated autoimmune hemolysis

Blood

Volumn 115, Issue 24, 2010, Pages 5080-5088

  Allhorn, Maria ^a   Briceño, Juana G ^b   Baudino, Lucie ^b   Lood, Christian ^a   Olsson, Martin L ^c   Izui, Shozo ^b   Collin, Mattias ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; ENDOGLYCOSIDASE S; ERYTHROCYTE ANTIBODY; GLYCOSIDASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 8; RABBIT ANTISERUM; REACTIVE OXYGEN METABOLITE; RHESUS D ANTIGEN; UNCLASSIFIED DRUG; ALLOANTIBODY; BACTERIAL PROTEIN; COMPLEMENT COMPONENT C1Q; NDOS PROTEIN, STREPTOCOCCUS PYOGENES; OXYGEN; RHO(D) ANTIBODY;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNITY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG INHIBITION; ERYTHROCYTE; ERYTHROPHAGOCYTOSIS; HEMOLYSIS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MONOCYTE; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SENSITIZATION; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECT; IMMUNOLOGY; METABOLISM; PHAGOCYTOSIS; RABBIT;

ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANIMALS; BACTERIAL PROTEINS; COMPLEMENT C1Q; ERYTHROCYTES; GLYCOSIDE HYDROLASES; HEMOLYSIS; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-8; ISOANTIBODIES; MICE; MICE, INBRED BALB C; MONOCYTES; OXYGEN; PHAGOCYTOSIS; RABBITS;

EID: 77954680167     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-08-239020     Document Type: Article

References (45)

1. Petz L, Garatty G. Immune Hemolytic Anemias (2nd ed). Philadelphia, PA: Churchill Livingstone; 2004.
2. Kavai M, Szegedi G. Immune complex clearance by monocytes and macrophages in systemic lupus erythematosus. Autoimmun Rev. 2007;6(7):497-502. (Pubitemid 47069975)
3. Daniels G. Naming blood groups and the genes that control them. ISBT Science Series. 2009;4(1):118-120.
4. Suto Y, Ishikawa Y, Hyodo H, Uchikawa M, Juji T. Gene organization and rearrangements at the human Rhesus blood group locus revealed by fiber-FISH analysis. Hum Genet. 2000;106(2):164-171.
5. Kumpel BM, Goodrick MJ, Pamphilon DH, et al. Human Rh D monoclonal antibodies (BRAD-3 and BRAD-5) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D- volunteers. Blood. 1995;86(5):1701-1709.
6. Kávai M, Gyimesi E, Szucs G, Szegedi G. Binding and endocytosis of erythrocytes sensitized with rabbit IgG via Fc gamma receptors of human monocytes. Immunology. 1991;74(4):657-660.
7. Schreiber AD, Frank MM. Role of antibody and complement in the immune clearance and destruction of erythrocytes: I. In vivo effects of IgG and IgM complement-fixing sites. J Clin Invest. 1972;51(3):575-582.
8. Clynes R, Ravetch JV. Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity. 1995;3(1):21-26.
9. Meyer D, Schiller C, Westermann J, et al. FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia. Blood. 1998;92(11):3997-4002.
10. Flesch BK, Voge K, Henrichs T, Neppert J. Fcgamma receptor-mediated immune phagocytosis depends on the class of FcgammaR and on the immunoglobulin-coated target cell. Vox Sang. 2001;81(2):128-133.
11. Davenport R. Cytokines and erythrocyte incompatibility. Curr Opin Hematol. 1994;1(6):452-456.
12. Hadley AG, Zupanska B, Kumpel BM, et al. The glycosylation of red cell autoantibodies affects their functional activity in vitro. Br J Haematol. 1995;91(3):587-594.
13. Kumpel BM, Wang Y, Griffiths HL, Hadley AG, Rook GA. The biological activity of human monoclonal IgG anti-D is reduced by beta-galactosidase treatment. Hum Antibodies Hybridomas. 1995;6(3):82-88. (Pubitemid 3008102)
14. Malaise MG, Hoyoux C, Franchimont P, Foidart JB, Mahieu PR. Effects of mannose and mannose derivatives on the clearance of IgG antibody-coated erythrocytes in the rat. Immunology. 1989;68(1):126-132.
15. Malaise MG, Franchimont P, Mahieu PR. The ability of normal human monocytes to phagocytose IgG-coated red blood cells is related to the number of accessible galactosyl and mannosyl residues in the Fc domain of the anti-red blood cell IgG antibody molecules. J Immunol Methods. 1989;119(2):231-239.
16. Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 2006;313(5787):670-673. (Pubitemid 44201145)
17. Nimmerjahn F, Anthony RM, Ravetch JV. Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity. Proc Natl Acad Sci U S A. 2007;104(20):8433-8437.
18. Collin M, Olsén A. EndoS, a novel secreted protein from Streptococcus pyogenes with endoglycosidase activity on human IgG. EMBO J. 2001;20(12):3046-3055.
19. Collin M, Svensson MD, Sjöholm AG, Jensenius JC, Sjöbring U, Olsén A. EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis. Infect Immun. 2002;70(12):6646-6651.
20. Allhorn M, Olin AI, Nimmerjahn F, Collin M. Human IgG/FcgammaR interactions are modulated by streptococcal IgG glycan hydrolysis. PLoS ONE. 2008;3:e1413. (Pubitemid 351234505)
21. Nandakumar KS, Collin M, Olsén A, et al. Endoglycosidase treatment abrogates IgG arthritogenicity: importance of IgG glycosylation in arthritis. Eur J Immunol. 2007;37(10):2973-2982.
22. Collin M, Shannon O, Björck L. IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions. Proc Natl Acad Sci U S A. 2008;105(11):4265-4270.
23. Tippett E, Fernandes LA, Rogerson SJ, Jaworowski A. A novel flow cytometric phagocytosis assay of malaria-infected erythrocytes. J Immunol Methods. 2007;325(1):42-50. (Pubitemid 47238288)
24. Collin M, Olsén A. Effect of SpeB and EndoS from Streptococcus pyogenes on human immunoglobulins. Infect Immun. 2001;69(11):7187-7189.
25. Bussolino F, Turrini F, Arese P. Measurement of phagocytosis utilizing [14C]cyanate-labelled human red cells and monocytes. Br J Haematol. 1987;66(2):271-274. (Pubitemid 17087428)
26. Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion. 1987;27(6):449-452.
27. Hadley A, Wilkes A, Poole J, Arndt P, Garratty G. A chemiluminescence test for predicting the outcome of transfusing incompatible blood. Transfus Med. 1999;9(4):337-342.
28. Basta M, Fries LF, Frank MM. High doses of intravenous immunoglobulin do not affect the recognition phase of the classical complement pathway. Blood. 1991;78(3):700-702.
29. Azeredo da Silveira S, Kikuchi S, Fossati-Jimack L, et al. Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody. J Exp Med. 2002;195(6):665-672.
30. Shibata T, Berney T, Reininger L, et al. Monoclonal anti-erythrocyte autoantibodies derived from NZB mice cause autoimmune hemolytic anemia by two distinct pathogenic mechanisms. Int Immunol. 1990;2(12):1133-1141.
31. Petry F, Botto M, Holtappels R, Walport MJ, Loos M. Reconstitution of the complement function in C1q-deficient (C1qa-/-) mice with wild-type bone marrow cells. J Immunol. 2001;167(7):4033-4037. (Pubitemid 32910849)
32. Labit C, Pierres M. Rat monoclonal antibodies to mouse IgG1, IgG2a, IgG2b, and IgG3 subclasses, and kappa chain isotypic determinants. Hybridoma. 1984;3(2):163-169.
33. Davenport RD, Burdick MD, Strieter RM, Kunkel SL. In vitro production of interleukin-1 receptor antagonist in IgG-mediated red cell incompatibility. Transfusion. 1994;34(4):297-303.
34. Davenport RD, Strieter RM, Standiford TJ, Kunkel SL. Interleukin-8 production in red blood cell incompatibility. Blood. 1990;76(12):2439-2442.
35. Wikman A, Axdorph U, Gryfelt G, Gustafsson L, Björkholm M, Lundahl J. Characterization of red cell autoantibodies in consecutive DAT-positive patients with relation to in vivo haemolysis. Ann Hematol. 2005;84(3):150-158. (Pubitemid 40260324)
36. Baudino L, Nimmerjahn F, Azeredo da Silveira S, et al. Differential contribution of three activating IgG Fc receptors (FcgammaRI, FcgammaRIII, and FcgammaRIV) to IgG2a- and IgG2b-induced autoimmune hemolytic anemia in mice. J Immunol. 2008;180(3):1948-1953.
37. Valent P, Lechner K. Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review. Wien Klin Wochenschr. 2008;120(5):136-151.
38. Olsson ML, Clausen H. Modifying the red cell surface: towards an ABO-universal blood supply. Br J Haematol. 2008;140(1):3-12.
39. Liu QP, Sulzenbacher G, Yuan H, et al. Bacterial glycosidases for the production of universal red blood cells. Nat Biotechnol. 2007;25(4):454-464. (Pubitemid 46572854)
40. Tarentino AL, Plummer TH. Enzymatic deglycosylation of asparagine-linked glycans: purification, properties, and specificity of oligosaccharide-cleaving enzymes from Flavobacterium meningosepticum. Methods Enzymol. 1994;230:44-57. (Pubitemid 24080126)
41. Collin M, Fischetti VA. A novel secreted endoglycosidase from Enterococcus faecalis with activity on human immunoglobulin G and ribonuclease B. J Biol Chem. 2004;279(21):22558-22570.
42. Albert H, Collin M, Dudziak D, Ravetch JV, Nimmerjahn F. In vivo enzymatic modulation of IgG glycosylation inhibits autoimmune disease in an IgG subclass-dependent manner. Proc Natl Acad Sci U S A. 2008;105(39):15005-15009.
43. Baggiolini M, Imboden P, Detmers P. Neutrophil activation and the effects of interleukin-8/neutrophil-activating peptide 1 (IL-8/NAP-1). Cytokines. 1992;4:1-17.
44. Nimmerjahn F, Ravetch JV. Fc-receptors as regulators of immunity. Adv Immunol. 2007;96:179-204.
45. Freeman AF, Holland SM. Persistent bacterial infections and primary immune disorders. Curr Opin Microbiol. 2007;10(1):70-75. (Pubitemid 46216875)